Difference between revisions of "Part:BBa I716155"
| Line 5: | Line 5: | ||
This is an enzyme involved in the heme biosynthetic pathway. Also called uroporphyrinogen III synthase. | This is an enzyme involved in the heme biosynthetic pathway. Also called uroporphyrinogen III synthase. | ||
| − | + | =IISER_Bhopal 2021= | |
| + | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
| + | During heme biosynthesis, this enzyme catalyses the asymmetric cyclization of linear tetrapyrrole to form a uroporphyrinogen III isomer. At the catalytic site, hydroxymethylbilane use as a substrate gives uroporphyrinogen III[1]. Guocheng Du et al. group identified that along with hemA and hemL, upregulation of hemD and hemF increases the 5-Aminolevulinic acid accumulation which is a promising source for cancer treatment[2]. | ||
| + | ===References=== | ||
| + | 1. Schubert, H. L., Phillips, J. D., Heroux, A., & Hill, C. P. (2008). Structure and Mechanistic Implications of a Uroporphyrinogen III Synthase−Product Complex. Biochemistry, 47(33), 8648–8655. https://doi.org/10.1021/bi800635y | ||
| + | |||
| + | 2. Zhang, J., Kang, Z., Chen, J., & Du, G. (2015). Optimization of the heme biosynthesis pathway for the production of 5-aminolevulinic acid in Escherichia coli. Scientific Reports, 5(1). https://doi.org/10.1038/srep08584 | ||
| − | |||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> | ||
<partinfo>BBa_I716155 SequenceAndFeatures</partinfo> | <partinfo>BBa_I716155 SequenceAndFeatures</partinfo> | ||
Revision as of 14:11, 9 October 2021
hemD
This is an enzyme involved in the heme biosynthetic pathway. Also called uroporphyrinogen III synthase.
IISER_Bhopal 2021
Usage and Biology
During heme biosynthesis, this enzyme catalyses the asymmetric cyclization of linear tetrapyrrole to form a uroporphyrinogen III isomer. At the catalytic site, hydroxymethylbilane use as a substrate gives uroporphyrinogen III[1]. Guocheng Du et al. group identified that along with hemA and hemL, upregulation of hemD and hemF increases the 5-Aminolevulinic acid accumulation which is a promising source for cancer treatment[2].
References
1. Schubert, H. L., Phillips, J. D., Heroux, A., & Hill, C. P. (2008). Structure and Mechanistic Implications of a Uroporphyrinogen III Synthase−Product Complex. Biochemistry, 47(33), 8648–8655. https://doi.org/10.1021/bi800635y
2. Zhang, J., Kang, Z., Chen, J., & Du, G. (2015). Optimization of the heme biosynthesis pathway for the production of 5-aminolevulinic acid in Escherichia coli. Scientific Reports, 5(1). https://doi.org/10.1038/srep08584
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]